CITIGROUP INC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$29,736,320
+19.1%
30,656,000
+20.6%
0.02%
+37.5%
Q2 2023$24,963,410
-9.1%
25,414,000
-5.0%
0.02%
-15.8%
Q1 2023$27,451,121
+2455.9%
26,756,000
+2543.9%
0.02%
+1800.0%
Q4 2022$1,074,036
+260.4%
1,012,000
+239.6%
0.00%
Q1 2022$298,000
-79.5%
298,000
-78.6%
0.00%
-100.0%
Q4 2021$1,453,000
+195.9%
1,390,000
+193.2%
0.00%
Q2 2021$491,000
-8.1%
474,000
-10.2%
0.00%
Q1 2021$534,000
-65.3%
528,000
-63.2%
0.00%
-100.0%
Q4 2020$1,541,000
-11.7%
1,436,000
-13.7%
0.00%0.0%
Q3 2020$1,745,000
+10164.7%
1,663,000
+11778.6%
0.00%
Q2 2020$17,000
+13.3%
14,0000.0%0.00%
Q1 2020$15,0000.0%14,0000.0%0.00%
Q4 2019$15,000
+36.4%
14,000
+27.3%
0.00%
Q3 2019$11,000
-94.2%
11,000
-94.1%
0.00%
Q1 2019$191,000
-72.6%
187,000
-73.3%
0.00%
-100.0%
Q4 2017$697,000
-65.6%
700,000
-65.0%
0.00%
-50.0%
Q3 2017$2,026,0002,000,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
KBC Group NV 400,000$40,316,0000.15%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders